Magnevist MRI Contrast Agent May Cause Hypersensitivity Reactions: FDA
Federal drug regulators are warning that some patients may have a hypersensitivity to Magnevist, an MRI contrast solution used to improve the outcome of MRI scans. …
«
»
Federal drug regulators are warning that some patients may have a hypersensitivity to Magnevist, an MRI contrast solution used to improve the outcome of MRI scans. …
Restrictive guidelines put in place on gadolinium-based contrast agents (GBCAs) used during some MRI examinations appear to be working, according to the findings of U.S. researchers, who report that they have not identified any new cases of nephrogenic systemic fibrosis (NSF) among individuals who received an enhanced MRI with contrast after the guidelines were adopted. …
The first trial over nephrogenic systemic fibrosis (NSF) from Omniscan, a gadolinium-based MRI contrast agent manufactured by GE Healthcare, was settled in a last minute deal reached the night before trial was set to begin in federal court in Cleveland on Monday.…
The FDA has asked a panel of outside experts to evaluate the risk of nephrogenic systemic fibrosis (NSF) with a new MRI contrasting agent proposed by Bayer AG. …
Trial has been schedule to begin early next year for a lawsuit involving allegations that a gadolinium-based MRI contrast agent led to the development of nephrogenic systemic fibrosis (NSF), a severe and debilitating injury. …
The FDA is banning the use of three major brands of MRI contrast agent on patients with kidney problems, and is forcing other manufacturers to change their labels to bring more attention to the risk of nephrogenic systemic fibrosis (NSF), a potentially fatal side effects of the gadolinium-based contrasting agents. …
Ominscan, Magnevist and Optimark are the three gadolinium-based MRI contrast agents associated with the highest number of nephrogenic systemic fibrosis (NSF) cases, according to new radiology industry safety standards. …
A Bermuda couple is planning to file a medical malpractice lawsuit against at U.S. hospital, claiming that doctors ignored FDA warnings and administered a gadolinium-based MRI contrast agent despite the wife’s known kidney problems, causing her to develop a rare and potentially life-threatening condition, known as nephrogenic systemic fibrosis (NSF). …
Bayer reports that it has reached settlement agreements with nearly half of the plaintiffs who have filed a Magnevist lawsuit, involving claims that the company’s gadolinium-based MRI contrasting agent caused users to develop a rare and potentially life-threatening condition, known as nephrogenic systemic fibrosis (NSF).…
GE Healthcare and a Danish scientist have reached a settlement in a libel lawsuit over statements made about the side effects of Omniscan, an MRI contrast agent that has been linked to nephrogenic systemic fibrosis (NSF), a severe and debilitating injury.…